ARO-HIF2 shows promise for advanced kidney cancer
A small phase 1b study of a new medicine called [...]
Lenvatinib plus pembrolizumab in for untreated and previously treated metastatic kidney cancer
Results from a phase Ib/II study looking at lenvatinib plus [...]
Safety and efficacy of tivozanib–nivolumab combination in patients with metastatic kidney cancer
In this phase 1b/2 study the researchers looked at a [...]
Safety and efficacy of TiNivo in patients with metastatic kidney cancer
Tivozanib is a drug that blocks the blood supply to [...]
Safety and efficacy of immunotherapy rechallenge in patients with kidney cancer
There are a number of immune checkpoint inhibitor drugs available [...]
Lenvatinib plus pembrolizumab shows promise in solid tumours
The combination of lenvatinib plus pembrolizumab has shown promise in [...]
Tivozanib has a better safety profile than other TKIs for the treatment of kidney cancer
A recent literature review and network meta-analysis of phase 2/3 [...]
Alternative schedule ipilimumab plus nivolumab for first-line treatment of advanced kidney cancer
The combination of nivolumab with ipilimumab has been proven to [...]
ASCO 2019: Safety and efficacy of immune checkpoint inhibitors in patients with pre-existing autoimmune disorders
This study was presented at the American Society of Clinical [...]
Real-world outcomes of nivolumab and cabozantinib for metastatic kidney cancer
A retrospective study using data from the International Metastatic Renal [...]
